Publication:
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report

dc.contributor.authorSİLİ, ULUHAN
dc.contributor.authorsSalmanton-García J., Marchesi F., Glenthøj A., Bilgin Y. M., Van Praet J., Dávila-Valls J., Martín-Pérez S., Labrador J., Van Doesum J., Falces-Romero I., et al.
dc.date.accessioned2022-12-28T15:54:23Z
dc.date.accessioned2026-01-11T06:19:13Z
dc.date.available2022-12-28T15:54:23Z
dc.date.issued2022-11-25
dc.identifier.citationSalmanton-García J., Marchesi F., Glenthøj A., Bilgin Y. M., Van Praet J., Dávila-Valls J., Martín-Pérez S., Labrador J., Van Doesum J., Falces-Romero I., et al., "Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report", HemaSphere, cilt.6, sa.11, 2022
dc.identifier.doi10.1097/hs9.0000000000000789
dc.identifier.issn2572-9241
dc.identifier.issue11
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85143836045&origin=inward
dc.identifier.urihttps://hdl.handle.net/11424/284566
dc.identifier.volume6
dc.language.isoeng
dc.relation.ispartofHemaSphere
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectSağlık Bilimleri
dc.subjectMedicine
dc.subjectInternal Medicine Sciences
dc.subjectInternal Diseases
dc.subjectHematology
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.subjectClinical Medicine (MED)
dc.subjectCLINICAL MEDICINE
dc.subjectHEMATOLOGY
dc.titleImproved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
301.1 KB
Format:
Adobe Portable Document Format